Novo co-led a second tranche that lifted Metagenomi’s series B round to $275m while crypto payment technology provider Wyre is shutting after a $1.5bn acquisition fell through.
M&A
Pharmaceutical firm Moderna has agreed to pay $85m to acquire OriCiro Genomics, a Japan-based developer of cell-free synthesis technology, allowing trading group Itochu and pharmaceutical company Asahi Kasei to exit. Coprorate venturing unit Itochu Technology Ventures took part in a $7.3m series B round in mid-2021 that increased the total raised by OriCiro to $10.9m, before Ashai Kahei added an undisclosed sum in June…
